Stock Snapshot from
Rexahn Pharmaceuticals IncAdd to My Watchlist
RNN:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
- 0.39Last
- 0.00 0.65%Today's Change
- 0.39Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.060 |
| EPS: Year Est. 12/13 ttm | -- |
| EPS: Quarterly Actual 3/13 | -0.01 |
| EPS: Quarterly Est. 6/13 | -- |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | 50.00 |
Company Description
| Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops signal inhibitor therapies for cancer, and treatments for central nervous system diseases. | |
| Revenue | $0 |
| Net Income | $-6 million |
| Total Assets | $15 million |
| Employees | 14 |
| Web Site | www.rexahn.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.